Last reviewed · How we verify
NCT05503342
Monitoring of Patients With Asthma Performed by a Clinical Pharmacist Using a Mobile Application
NA trial testing Mobile Application in Asthma in 40 participants. Completed in 23 April 2022.
23 April 2022
Quick facts
| Lead sponsor | Rafael Stelmach |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 40 |
| Start date | 29 November 2019 |
| Primary completion | 23 April 2022 |
| Estimated completion | 23 April 2022 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Mobile Application
- Asthma control assessment
Conditions studied
- Asthma — all drugs for Asthma →
Sponsor
Rafael Stelmach — full company profile →
Who can join
Adults 18 to 65, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Asthma is a chronic inflammatory disease that affects the lungs. In Brazil it is responsible for about 4 to 8 deaths per day. Pharmacotherapeutic follow-up programs for people with asthma have a positive impact on treatment adherence, as well as on education about the disease, helping patients in their self-management and recognition of their health status. The use of mobile applications that assist in the monitoring and self-management of people with asthma has been increasing significantly, but we do not have much information about their real impact on the control of the disease. Thus, the aim of this study is to evaluate the use of a mobile application in the monitoring and self-management of symptoms in adults with asthma in a pharmaceutical care program at a university outpatient clinic in São Paulo, Brazil.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05503342
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mobile Application
Trials testing the same drug.
- NCT06613451 — The Effect of Mobile Application Use on Drug Administration Knowledge and Skill Level of Pediatric Nursing Students · NA · completed
- NCT06004700 — Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits · NA · active not recruiting
- NCT06542679 — Pregnancy Weight Management Mobile Health App · NA · active not recruiting
- NCT06619431 — Pilot Test of a Mobile App That Helps Spanish-speakers Find Mental Health Services in the US. · completed
- NCT06168656 — Examining a Mobile App's Impact on Expectant Fathers' Fear of Childbirth and Paternal Attachment · NA · unknown
Other recruiting trials for Asthma
Currently open trials in the same condition.
- NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
- NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
- NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
- NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
- NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting
Other Rafael Stelmach trials
Trials by the same sponsor.
- NCT01089322 — Risk Factors Associated to Difficult-to-control Asthma · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05503342 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rafael Stelmach
- Last refreshed: 16 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05503342.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing